Calcium hydride demonstrates promising therapeutic potential for osteomyelitis treatment through a novel triple mechanism involving hydrogen generation, alkaline environment creation, and calcium ion delivery, effectively inhibiting bacterial growth while promoting bone regeneration in infected tibia models. This bioactive metal hydride approach offers a potential alternative strategy to address antibiotic-resistant bacterial infections and represents a significant advancement in treating deep-site bone infections with high clinical morbidity.
Plain-Language Summary
Researchers tested calcium hydride, a compound that releases hydrogen gas, alkaline chemicals, and calcium ions when exposed to water, as a potential treatment for osteomyelitis (a serious bone infection caused by bacteria). In laboratory and mouse studies, calcium hydride killed bacteria through multiple mechanisms: it created an alkaline environment toxic to bacteria, caused calcium buildup inside bacterial cells, and generated hydrogen gas that damaged bacterial membranes. When applied to infected mouse bones, the treatment reduced bacteria, decreased inflammation, and promoted new bone growth.
Abstract
Osteomyelitis with high mortality and disability rates is a common clinical disease caused by a bacterial infection that is difficult to cure. Considering the stubborn nature and depth of tissue infection, rapid and effective treatments for osteomyelitis remain an enormous challenge. Calcium hydride (CaH2), as efficient hydrogen/alkaline/calcium donors, is employed for combined osteomyelitis therapy. CaH2 reacts with water to sufficiently generate a strong alkali environment with hydroxide anions (OH-) to inhibit bacterial proliferation and induce bacterial death. The released calcium ions (Ca2+) induce calcium overload to kill bacteria first and then serves as calcium source to promote new bone formation. Another byproduct, hydrogen enhances the bacterial membrane permeability and scavenges excess reactive oxygen species (ROS). After incubation with bacteria, CaH2 significantly increases the permeability of the bacterial membrane, therefore increasing the entry of OH- and Ca2+ into bacterial cells, thereby leading to significant bacterial death. After being applied to S. aureus-infected mouse tibia osteomyelitis, CaH2 materials efficiently kill bacteria, relieve local inflammation, and promote new bone formation in a short time. Overall, bioactive metal hydride-associated "triple" hydrogen/alkaline/calcium therapy provides a new idea for the treatment of deep-site bacterial infection, which is beneficial for relieving the pressure caused by antibiotic-resistant bacteria.
